Farms.com Home   News

CN Rail Makes Competing Offer For Kansas City Southern

CN Rail has made a competing proposal to combine with Kansas City Southern (KCS) railway in a cash-and-stock transaction valued at $33.7 billion.
 
CN says its proposal represents a 21% premium over implied value of CP Rail's transaction, wich was announced last month.
 
“We firmly believe our proposal is far superior to KCS’ existing agreement with CP because it offers superior financial value over the immediate and long-term, a more complementary strategic fit, greater choice and efficiencies for customers and enhanced benefits for employees and local communities. We look forward to engaging constructively with KCS’ Board and all relevant stakeholders to deliver this superior transaction,” said Robert Pace, Chair of the Board of CN.
 
CN currently estimates that the combination would result in EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) synergies approaching $1 billion annually, with the vast majority of synergies coming from additional revenue opportunities.
 
“CN is ideally positioned to combine with KCS to create a company with broader reach and greater scale, and to seamlessly connect more customers to rail hubs and ports in the U.S., Mexico and Canada. CN and KCS have highly complementary networks with limited overlap that will enable them to accelerate growth in single-owner, single-operator, endto-end service across North America. With safer service and better fuel efficiency on key routes from Mexico through the heartland of America, the result will be a safer, faster, cleaner and stronger railway,” added JJ Ruest, president and chief executive officer of CN.
Click here to see more...

Trending Video

A new era in biostimulants and bionutritionals

Video: A new era in biostimulants and bionutritionals


In response to the growing need for efficient, effective biosolutions, HGS BioScience continues to expand its footprint in the bionutritional and biostimulant market with the acquisition of NutriAg, Ltd. The Paine Schwartz Partners-backed HGS BioScience is a global leader in humic and fulvic acid products. Toronto-based NutriAg is an innovator in bionutritional technologies with a deep R&D engine. North American growers and retailers will benefit from:

• Solutions across the biostimulant spectrum - including humics, fulvics, bionutritionals, carbohydrate chelation, amino acids, plant and seaweed extracts, and microbial technologies.
• A portfolio and R&D pipeline of science-backed solutions proven to drive crop productivity and farm profitability.
• Actionable nutrient insights and recommendations based on data specific to their farm and cropping goals with the NutriAnalytics platform